Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
ReN001
Also known as: Neural stem cells
print preview
bookmark
share with colleague
General Information
Company
ReNeuron Group plc
Description
Cell therapy consisting of neural stem cells derived from ReNeuron's c-mycER technology
Molecular Target
Not applicable
Mechanism of Action
Cell therapy
Latest Stage of Development
Phase I
Indication
Stroke
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy